FindTrial
Sign In

Efficacy and safety of ozonized saline infusion for chronic pain

Efficacy and safety of ozonized saline infusion for chronic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017979
Enrollment
Unknown
Registered
2018-08-25
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Interventions

Control:Pure oxidized saline
Ozonized saline :Introvenously infusion of ozonized saline

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Chronic pain lasted more than 3 months; 2) No important system complications, such as COPD, heart disease, etc.; 3) NRS pain score 6-10 points; 4) Aged 18-80 years old.

Exclusion criteria

Exclusion criteria: 1) Ozone allergy; 2) Patients with a history of asthma; 3) patients with glucose-6-phosphatase deficiency; 4) patients with hyperthyroidism; 5) The results of the examination suggest that other system diseases are coexisting.

Design outcomes

Primary

MeasureTime frame
Pain intensity score;Inflationary factors;—

Countries

China

Contacts

Public ContactSong Cao

Affiliated Hospital of Zunyi Medical University

caosong4321@163.com+86 18212170434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026